The 2009 Northeast Rabies Challenge Fund Seminar & Benefit will be held March 14, 2009 at Rutgers University, New Brunswick, NJ. The seminar benefits the Rabies Challenge Fund Charitable Trust, an organization devoted to helping your pets live longer, healthier lives.
At the benefit you can meet and hear two of the foremost experts in the field of veterinary vaccine research:
* Dr. W. Jean Dodds, (pictured) world-renowned veterinary research scientist and practicing veterinarian
* Dr. Ronald D. Schultz, leading authority on veterinary vaccines and Chair of the Department of Pathobiological Sciences at the University of Wisconsin School of Veterinary Medicine.
Even if you don't live near New Jersey, you can still support RCF and see/hear Dr. Dodds speak live via the Internet. The live seminar starts at 2PM EDT, and will be broadcast on the HyCaliber Video website. It will be limited to 300 online virtual attendees, and the price of this live stream is $55.00 with the proceeds going to support further vaccine research.
About the Rabies Challenge Fund:
Financed by The Rabies Challenge Fund, one of the most important vaccine research studies in veterinary medicine is underway at the University of Wisconsin School of Veterinary Medicine in Madison. Dr. Ronald Schultz, a leading authority on veterinary vaccines and Chair of the Department of Pathobiological Sciences, has begun concurrent 5 and 7 year challenge studies to determine the long-term duration of immunity of the canine rabies vaccine, with the goal of extending the state-mandated interval for boosters. These will be the first long-term challenge studies on the canine rabies vaccine to be published in the United States.
Scientific data indicates that vaccinating dogs against rabies every three years, as most states require, is unnecessary. Studies have shown the duration of protective immunity as measured by serum antibody titers against rabies virus to persist for seven years post-vaccination. By validating the 'true' life of rabies virus immunity and moving to five and hopefully seven years, we will decrease the risk of adverse reactions in our animals and minimize their repeated exposure to foreign substances.